Exchange: NASDAQ·Updated 04:30 AM EDT
DYAI logo

DYAI Dyadic International Inc., DE

$0.484
$0.00
(0.00%)
Pre-Market
Prev Close $0.484
EarningsNov 11
Mkt Cap$19.39M
Vol319.00

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
65

Bullish Sentiment

How do you feel about DYAI?

Advertisement|Remove ads.